| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Reproductive Medicine and Neuroscience and the
Center for Molecular Genetics (C.G.K., M.E.C., P.L.M.) University
of California, San Diego La Jolla, California 92093-0674
Dipartmento di Biologia e Tecnologia Istituto
Scientifico H. S. Raffaele (G.L., E.B.) 20132 Milano,
Italy
Centro per lo studio della Farmacologia Cellulare e
Molecolare (E.B.) Consiglio Nazionale delle Ricerche
20129 Milano, Italy
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Low-stringency hybridization cloning in mice has revealed a family of homeodomain proteins, termed Otx, closely related to D. melanogaster orthodenticle (otd) gene (7, 8). In Drosophila, expression patterns of the Otx proteins are restricted to the anterior head structures. In vertebrates, the most conserved Otx family member genes are Otx1 and Otx2 (9, 10, 11, 12, 13). Mouse knock-out experiments have shown that these genes are involved in anterior brain patterning; Otx2-/- mice lack forebrain and midbrain regions (14, 15, 16), while Otx1 -/- mice show several brain abnormalities (17). The early expression pattern of these genes, which has been studied in detail in Xenopus, suggests an even earlier role in development (10, 11, 12, 18).
The homeobox is a 180-bp DNA sequence segment that encodes a 60-amino acid residue domain, the homeodomain. The homeodomain of Otx and bicoid proteins is characterized by the presence of a conserved lysine at position 50; in other homeodomain-containing proteins, such as Antennapedia (Antp), it has been shown that the corresponding residue, a glutamine, directly contacts DNA bases (19). This amino acid difference between Otx and Antp homeodomains may be responsible for the differences between the Otx and Antp DNA recognition sequences. Previous studies from our group (13) have shown that Otx proteins can bind to the same functional target sequence motif recognized by bicoid on the hunchback promoter (20). We have also demonstrated that Otx1 and Otx2 proteins can transactivate a reporter gene, through a multimerized copy of the Otx/bicoid target sequence.
Using double immunohistochemistry, we have demonstrated previously that the cells that express Otx2 in the embryonic olfactory placode also express GnRH (21). GnRH is a decapeptide hormone that is released from a subset of hypothalamic neurons that controls many aspects of reproduction (22). GnRH-expressing neurons are found scattered throughout the basal forebrain and the rostral hypothalamus in the adult; however, they originate in the olfactory placode and migrate into the hypothalamus at E13 (23, 24, 25). Fewer than 800 GnRH neurons are present in the adult mouse hypothalamus (26), and these are not localized in a nucleus. Rather, they are scattered in several regions and can be found even along the original migratory route from the olfactory placode.
The low number and scattered distribution of GnRH neurons in the adult have made it difficult to study the molecular mechanisms underlying tissue-specific regulation of GnRH expression. We created a cultured cell model system to study GnRH gene regulation using targeted tumorigenesis in transgenic mice (27). This clonal GnRH-secreting hypothalamic cell line, GT17, is an excellent model system for the study of neuron-specific expression of the GnRH gene since these cells have retained many characteristics of GnRH neurons in vivo, including distinct neuronal morphology, expression of differentiated neuronal markers, and secretion of GnRH in response to appropriate signals (27, 28, 29, 30). The GT17 cells have been used to define a neuron-specific enhancer region (31) and demonstrate transcriptional activity of the GnRH proximal promoter (32, 33). Nuclear extracts from this cell line contain specific transcriptional regulatory proteins that bind both the enhancer and the promoter regions of the GnRH gene (31, 32, 33, 34, 35).
Recently, many new transcription factors have been isolated based on homology to known transcription factor families. Unfortunately, this approach does not provide any information on the target genes for these potential regulatory proteins. To find potential target genes for Otx, we developed a novel computer algorithm (36, 37) to search a sequence database for potential Otx binding sites. Interestingly, we found that the promoter of the GnRH gene from many species contains a previously undetected consensus Otx/bicoid target sequence. Herein we demonstrate that Otx2 regulates the rat GnRH gene through this Otx/bicoid site in the proximal promoter. To date, a few potential Otx target genes have been described in the sea urchin (38, 39, 40) and in the human tenascin-C promoter (41). The rat GnRH promoter Otx/bicoid site represents a natural functional binding site for Otx2 in the promoter of a brain-specific protein. These studies support the hypothesis that Otx2 participates in the development of the GnRH neuron and/or in the neuron-specific expression of the GnRH gene in the adult hypothalamus.
| RESULTS |
|---|
|
|
|---|
One of these genes, the GnRH gene, is of particular interest because
the Otx/bicoid site is found in the proximal promoter of GnRH genes and
is conserved across several vertebrate species, as shown in Fig. 1
. In addition, the areas in which GnRH
is expressed are areas dependent upon Otx2 for development. GnRH
expression is limited to a subpopulation of hypothalamic neurons that
are born in the olfactory placode, which is absent in the Otx2
knock-out mouse (14, 15, 16). In contrast, hypothalamic GnRH expression is
unaltered in Otx1 -/- mice (42).
|
|
Otx2 Binds to the GnRH Otx/Bicoid Site
To determine whether the GnRH Otx/bicoid site could bind Otx2
in vitro, we performed an electrophoretic mobility shift
assay (EMSA) experiment in which we incubated recombinant mouse Otx2
protein with a radiolabeled, double-stranded oligonucleotide carrying
the -163 to -133 portion of the rat GnRH gene (rGnRH Otx probe, Fig. 3A
). This fragment contains a putative
Otx/bicoid site starting at position -153. As shown in Fig. 3B
, recombinant Otx2 protein binds to the rGnRH Otx probe (lane 1). This
binding is competed by a 200-fold molar excess of self-competitor (lane
2) and by a 200-fold molar excess of the multimerized bicoid target
sequence oligonucleotide (multi bicoid, lane 4) that has also been
shown to recognize the Otx2 protein (13). The same Otx2 protein complex
is not competed by a 200-fold molar excess of a mutated rGnRH Otx
oligonucleotide (rGnRH mut, lane 3), in which four bases of the
Otx/bicoid site had been changed to G residues (see
underlined bases in Fig. 3A
). Therefore, these EMSA
experiments show that the rat GnRH gene promoter contains a Otx/bicoid
site that can specifically bind to recombinant Otx2 protein in
vitro.
|
The bicoid oligonucleotide, which contains an Otx/bicoid site from the hunchback promoter (20), was also used as a probe in an EMSA with nuclear extracts from GT17 cells (lanes 1116). This probe was incubated with extracts without competitor (lane 11), with 100-fold molar excess self-competition (lane 12), 100-fold molar excess rGnRH Otx competition (lane 13), 100-fold molar excess rGnRH mut competition (lane 14), 1 µl of Otx2 antibody (lane 15), or 1 µl of normal rabbit total IgG (lane 16). The bicoid probe forms a protein-DNA complex that comigrates with the specific band obtained using the labeled rGnRH oligonucleotide. This band is competed by itself and by the rGnRH oligonucleotide; incubation with Otx2 antibody also prevents the binding. The two bands that appear above the specific band are not affected by the Otx2 antibody, and we do not know their identity. The same two unidentified upper bands appear with NIH3T3 nuclear extracts on the singular bicoid consensus site oligonucleotide, whereas the specific Otx2 complex is not detected in NIH3T3 extracts (lanes 1719).
This Otx2 antibody is thought to have low-level cross-reactivity with Otx1 (and the antibody for Otx1 also is thought to have low level cross-reactivity with Otx2); however, Otx1 and Otx2 are substantially different in size (355 amino acids vs. 289 amino acids, respectively), a difference that can easily by detected through EMSA. Although Otx1 was not detected in GT17 cells by Northern or Western blotting (data not shown), we further addressed this issue using nuclear extracts from NIH3T3 cells transfected with expression vectors for Otx1 or Otx2 in EMSA with the rGnRH Otx/bicoid probe or the singular bicoid consensus site probe. The band from the NIH3T3 cells transfected with Otx2 comigrated with that formed by the GT17 nuclear extract, while the band from the NIH3T3 cells transfected with Otx1 is retarded to a greater extent (data not shown). Although the Otx1 cDNA we used is human, the human and mouse Otx1 proteins differ in length by only one amino acid (with nine substitutions). Thus, the complex we have studied comigrates with Otx2 but not with Otx1 from transfected NIH3T3 cells. These data taken together demonstrate that GT17 cells contain Otx2 that is capable of binding specifically to the Otx/bicoid site in the rat GnRH promoter.
Activation of GnRH Transcription by Otx2
The functional relevance of Otx2 binding to the GnRH promoter
region was assessed using transient transfection analyses with plasmids
containing either the GnRH enhancer linked to the GnRH promoter or the
GnRH promoter alone (see Materials and Methods). In the
first experiment (Fig. 4
), the effect of
mutations in the Otx/bicoid site on the basal transcriptional activity
of a GnRH promoter plasmid was assayed in GT17 cells. In all cases,
mutagenized bases were the same as those that abolished Otx2 binding
in vitro (Fig. 3
). When four nucleotides in the center of
the Otx/bicoid site were changed to G residues in the GnRH promoter,
transcription measured by the luciferase reporter gene was reduced by
more than 50% (Fig. 4
, left panel). An even more dramatic
effect was seen when using a reporter gene that contains the 300-bp
GnRH neuron-specific enhancer upstream of the promoter (Fig. 4
, right panel). In this case, the activity detected with the
mutated plasmid is only about 20% of the wild-type activity. Taken
together, these results show that the Otx2 binding element in the GnRH
promoter is important for both full basal and enhancer-driven
transcription of the GnRH gene in GT17 cells.
|
The heterologous RSV enhancer combined with the rGnRH promoter yields a
plasmid that isolates the contribution of the rGnRH promoter to the
cell type specificity. Transient transfections of this plasmid into
GT17 and NIH3T3 cells showed a significantly lower level of
transcription in NIH3T3 cells (Fig. 5A
).
When the rGnRH Otx/bicoid site has the core four bases mutated to GGGG,
the statistically significant difference in transcription between the
GT17 and NIH3T3 cells is eliminated (Fig. 5A
). These results show
that the Otx/bicoid site contributes to the cell type-specific
transcription of the GnRH gene.
|
To determine whether overexpression of the Otx2 protein in GT17 cells
could affect the level of GnRH expression, we cotransfected an Otx2
expression plasmid with the GnRH promoter reporter plasmid
(rGnRHp-luc). This combination resulted in a statistically significant
increase (
50%) in the activity of the reporter gene (Fig. 6
). Since GT17 cells already contain
Otx2 protein and the system may be nearly saturated, this degree of
transactivation is appropriate. The effect of overexpression of Otx2 is
dependent on the presence of a functional Otx/bicoid site, since it is
not observed using the GnRH promoter reporter gene with a mutated Otx
binding site (Fig. 6
).
|
| DISCUSSION |
|---|
|
|
|---|
Previous studies have identified the importance of two DNA regions for correct expression of the GnRH gene in transfected GT17 cells (31). These two regions are the 300-bp GnRH enhancer, located 1.8 kb upstream of the transcription start site (31), and the 173-bp conserved GnRH proximal promoter region (32, 33). In this report, we have shown that the conserved GnRH proximal promoter contains an Otx2 binding site and that the GT17 hypothalamic cell line, which secretes GnRH, contains Otx2. Further we show that Otx2 binds to the GnRH promoter Otx/bicoid site, that this Otx2 binding site is necessary for both basal and enhancer-driven transcription of the GnRH gene in GT17 cells, and that it contributes to cell-type specific transcription of the GnRH gene. Lastly, cotransfection with an Otx2 expression vector activates the GnRH promoter through the Otx2 binding site, indicating that Otx2 plays a role in GnRH expression. Transgenic mouse experiments have shown that the GnRH promoter (as well as the enhancer) is important for specifying GnRH expression to the GnRH neurons in the hypothalamus. The combination of these two regulatory regions is sufficient to target appropriate transcription of a ß-galactosidase reporter gene in the GnRH neurons of transgenic mice, while the enhancer linked to a heterologous promoter (RSV) is not sufficient (M. Lawson and P. L. Mellon, personal communication). Thus, the GnRH promoter region contributes to neuron specificity of the GnRH gene in vivo. The Otx2 binding site is found from -153 to -146 of the rat GnRH gene within this crucial proximal promoter region.
DNase I footprint analysis of the rat GnRH proximal promoter region revealed seven distinct footprints bound by GT17 nuclear proteins (32). The Otx2 binding element falls near the 5'-end of footprint 6, which extends from -158 to -129 of the promoter region. Deletion of a larger region carrying this element (a -173 truncation as compared with a -126 truncation) demonstrated a 2-fold decrease in expression in GT17 cells (32, 33). Here, we show that a specific mutation of the Otx/bicoid site decreases expression by 80% in transiently transfected GT17 cells, indicating that the important element in this region is the Otx/bicoid site (the difference in degree of decrease due to deletion or internal mutation may be due to the use of luciferase in this study and chloramphenicol acetyl transferase as the reporter gene in the previous study). Further, cotransfection with an Otx2 expression vector activates through this element, demonstrating the capacity of Otx2 to regulate directly GnRH gene expression.
In addition to Otx2, other homeobox protein binding sites have been mapped both within the GnRH enhancer and the GnRH promoter. The Oct-1 POU homeodomain transcription factor is essential for activity of the rat GnRH enhancer (35) and promoter (33). POU homeodomain proteins are also known to interact specifically with a number of other DNA-binding proteins (43), some of which are other POU-domain transcription factors (44). Interestingly, a novel Otx-related homeodomain transcription factor, P-Otx, has been identified recently on the basis of its ability to interact with the transactivation domain of the pituitary-specific POU domain protein, Pit-1 (45). Hence the Otx and POU domain families of transcription factors can interact directly and might interact to produce neuron specificity of GnRH gene expression.
Recently, a functional SCIP/Oct-6/Tst-1 binding site has been mapped to the rat GnRH promoter at -151, in a position partially overlapping the Otx binding-site (46). SCIP/Oct-6/Tst-1 is a brain- and testis-specific member of the POU homeodomain transcription factor family (5, 47, 48, 49, 50) and is found in GT17 cells (35). When SCIP is overexpressed in GT17 cells, inhibition of rat GnRH transcription is seen (46). This finding suggests possible competition between the overexpressed SCIP and the endogenous Otx2 for binding to this region of the GnRH promoter. Further studies will be needed to elucidate the intriguing possibility of interaction between Otx and other brain factors, such as SCIP/Oct-6/Tst-1 and Oct-1, and their integration at the level of the GnRH promoter or other brain-specific promoters.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Immunohistochemistry
Immunohistochemistry was carried out according to MacConell
et al. (51). For colocalization, 30-µm adult male mouse
brain sections were stained with polyclonal rabbit
LR1 antiserum [directed against GnRH (52, 53)],
visualized with a brown reaction product from a DAB reaction and a
polyclonal rabbit Otx2 antiserum (21) visualized with a blue-black
product from a DAB-nickel mixture.
Plasmid Constructions and Block Replacement Mutagenesis
The reporter plasmid rGnRHe/rGnRHp-luc contains the rat GnRH
enhancer (31) (positions -1571 to -1863 relative to the transcription
start site) fused in reverse orientation to the GnRH minimal promoter
(positions -173 to +112 relative to the transcription start site)
upstream of the luciferase reporter gene. The reporter plasmid
rGnRHp-luc contains only the rat GnRH minimal promoter upstream of the
luciferase gene. The -173 (SmaI) to +112 (BglII)
rat GnRH promoter (31) was cloned into pGL3 basic (Promega Corp., Madison, WI). The enhancer fragment (-1571 to -1863)
from ENH-173 (54) was obtained by cutting with SmaI and
SalI and filling it in with Klenow. It was then inserted in
the reverse orientation upstream of the rGnRHp-luc plasmid, cut with
the same enzyme.
rGnRHe/rGnRHp-luc was then used as the template DNA for a PCR-based
mutagenesis method to make a mutation in the Otx2 binding site. The
position of the Otx/bicoid site is at -146/-153. The block
replacement mutation changed the core TAAT bases between -148 to -151
of the GnRH promoter to GGGG (Fig. 3A
). PCR primers were designed for
the sense and the antisense strands of the promoter, extending six
bases beyond the 5'-end and 14 bases beyond the 3'- end of the
mutagenized site. Two separate PCR reactions were assembled with the
sense mutagenesis primer (5'-GGTTTGGGCCCTTAGAATGGTG) and the antisense
vector primer (pGL3rev, Promega Corp.) combined in one
reaction and the antisense mutagenesis primer
(5'-TAAGGGCCCCAAAACCCAGACATG) and sense vector primer (RV primer 3,
Promega Corp.) combined in another reaction. The primary
products were electroeluted to purify them away from excess primers.
The sense and antisense primary PCR products have 16 bases overlapping,
including the mutagenized site. They were combined in equal amounts,
denatured, and allowed to anneal, creating some heteroduplex species.
Using both of the vector primers, a product equivalent to
rGnRHe/rGnRHp-luc, except for the introduced mutation, was amplified.
The secondary PCR product was digested with MluI and
NcoI and inserted back into pGL3, digested with the same
enzymes. The sequence of the fragment obtained by PCR was determined
using dideoxy-chain termination reactions in the presence of
[
32P]-dATP, 3000 Ci/mmol (NEN Life Science Products, Boston, MA) and Sequenase (Amersham Pharmacia Biotech, Arlington Heights, IL) under the conditions
described by the manufacturer. The promoter alone mutant (rGnRHp-luc)
was created by digesting the mutant rGnRHe/rGnRHp-luc construct with
MluI and XmaI, filling in with Klenow, and
cloning it back into pGL3.
The RSVe/RSVp-luc plasmid includes the RSV enhancer fused to the RSV promoter in the pGL3 basic plasmid (Promega Corp.). The coding region for luciferase was replaced with the coding region for ß-galactosidase to create the RSVe/RSVp-gal plasmid. The RSV enhancer-GnRH promoter-luciferase plasmid (RSVe/rGnRHp-luc) and the rGnRH enhancer-RSV promoter-luciferase (rGnRHe/RSVp-luc) plasmid each involve the replacement of one of the RSV regulatory regions with the corresponding GnRH regulatory region. The phosphorylated, double-stranded oligonucleotide corresponding to bases -163 to -133 of the rGnRH promoter was ligated into both the rGnRHe/RSVp-luc and RSVe/RSVp-luc plasmids after they were digested with SmaI, which is located at the junction of the specified enhancer and promoter to create rGnRHe/163133/RSVp-luc and RSVe/163133/RSVp-luc.
The full-length mouse Otx2 cDNA sequence was cloned into the mammalian expression vector pSG-5, under the control of the SV40 early promoter (pSG-mOtx2). This pSG-mOTX2 construct was generated by cloning into the EcoRI site of pSG-5 a 900-bp fragment containing the full-length cDNA of mouse Otx2 (a gift from Antonello Mallamaci).
Cell Culture and Transfections
GT17 cells (27) and NIH3T3 cells were used in transient
transfections. Cells were maintained in DMEM with 10% FBS, penicillin
(100 U/ml), streptomycin (0.1 mg/ml), and 4.5% glucose in an
atmosphere with 5% CO2. Transient transfections
(for Figs. 4
and 6
) were performed using calcium phosphate precipitates
containing 8 µg plasmid DNA, 4.88 µg of Otx2 or 4.08 µg of empty
vector control (molar equivalents), and 3 µg internal control plasmid
[herpes virus thymidine kinase (TK) promoter-ß-galactosidase] in
10-cm petri dishes. Cells were incubated for 16 h with the DNA
precipitates, followed by washing twice with PBS and then adding new
medium. The cells were incubated 30 h more before harvesting with
a rubber policeman into 0.15 M NaCl, 1 mM EDTA,
and 40 mM Tris, pH 7.4. Cell pellets were obtained by
centrifugation. Resuspension in lysis buffer (100 mM
potassium phosphate, pH 7.8, 0.2% Triton X-100) yielded cellular
proteins. ß-Galactosidase assays were performed as directed by the
manufacturer (Tropix, Bedford, MA) after heat inactivation of the
cellular extracts. Luciferase assays were performed as previously
described (35). Luciferase activity was divided by the internal control
ß-galactosidase values to control for transfection efficiencies
between plates. Values were normalized to wild-type GnRH regulatory
region with empty vector control.
The comparison of transcription in GT17 and NIH3T3 cells (shown in
Fig. 5
, A and B) involved transient transfections in 6-cm petri dishes
with the FuGENE 6 reagent (Roche Molecular Biochemicals,
Indianapolis, IN). Cells were maintained as above. Reporter plasmid DNA
(1.5 µg) and 0.5 µg of internal control DNA plasmid were mixed with
3 µl of FuGENE. FuGENE was used according to the manufacturers
directions. The mixture was incubated with the cells for 24 h. The
cells were then washed and harvested as above. The ratio of
RSVe/RSVp-luc to RSVe/RSVp-gal in the three control plates was set to
one in both GT17 and NIH3T3 cells and used for normalization of the
rest of the plates.
Nuclear Extracts and EMSA
The recombinant mouse Otx2 protein used in the EMSAs has been
previously described (21). The method for Fig. 3B
came from Clark and
Mellon (35). The procedure for Fig. 3C
follows: nuclear extracts used
for the experiment in Fig. 3C
were prepared according to Clark and
Mellon (35). Annealed oligonucleotides (1 pmol, Operon Technologies, Alameda, CA) were phosphorylated with
[
-32P]ATP (6000 Ci/mmol; NEN Life Science Products) and T4 polynucleotide kinase. Then, probes
were purified over a MicroSpin G-50 column (Pharmacia Biotech, Piscataway, NJ). The 10-µl reaction mixes contained 1
µg of protein and 1 fmol probe in 100 mM KCl, 37
mM HEPES (pH 7.9), 2.5 mMM EDTA,
1.25 mM dithiothreitol, 12.5% glycerol, and 4
mM phenylmethylsulfonyl fluoride. In the appropriate
reactions, 100 fmol (100x labeled probe) of competitor or 1 µl
antibody (or control rabbit IgG) were added 10 min before the addition
of probe. The probe was added and incubated for 5 min before loading
onto a 5% polyacrylamide nondenaturing gel that had prerun for 30 min.
After 2 h at 200 V, gels were dried under vacuum and then exposed
to film at room temperature for 13 days.
Northern Blot Analysis
RNA for Northern hybridization analysis was prepared according
to the protocol provided with the Trizol Reagent (Life Technologies, Inc., Gaithersburg, MD). To prepare the polyA+
RNA, the PolyATtract mRNA Isolation System IV (Promega Corp.) was used according to the manufacturers instructions.
One microgram of this polyA+ RNA (either from GT17 or NIH3T3 cells)
was loaded onto a 1% agarose gel and transferred to Hybond-N+ membrane
(Amersham Pharmacia Biotech) by capillary blotting. The
filter was prehybridized in 25% formamide buffer at 55 C and then
hybridized with 1,000,000 cpm of Otx2 probe for 16 h. The probe
itself was made by incubating the 900-bp EcoRI fragment of
pSG-mOTX2 with Klenow and [
-32P]ATP (6000
Ci/mmol, NEN Life Science Products) and then purifying it
over an S-200 HR column (Pharmacia Biotech). The filter
was washed in 0.1% SDS at 65 C for 40 min, dried, and then exposed to
film at -70 C with an intensifying screen for 5 days.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
This work was supported by the NIH Grant R01 DK-44838 to P.L.M. and by grants from the EC BIOTECH (Nos. 0378 and 0042) and BIOMED (No. 0777) Programmes, the Telethon-Italia Programme (No. D78), and the Italian Association for Cancer Research (AIRC) to E.B. C.G.K. was supported by a predoctoral fellowship from the Howard Hughes Medical Institute, and M.E.C. was supported by a fellowship from the American Cancer Society and the National Alliance for Research on Schizophrenia and Depression Foundation.
1 These authors contributed equally. ![]()
2 Present address: Neurocrine Biosciences, 10555 Science Center Drive,
San Diego, California, 92121. ![]()
Received for publication October 6, 1999. Revision received May 5, 2000. Accepted for publication May 9, 2000.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. H. Kim, A. Wolfe, R. N. Cohen, S. C. Eames, A. L. Johnson, C. N. Wieland, and S. Radovick In Vivo Identification of a 107-Base Pair Promoter Element Mediating Neuron-Specific Expression of Mouse Gonadotropin-Releasing Hormone Mol. Endocrinol., February 1, 2007; 21(2): 457 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Tang, M. Mazur, and P. L. Mellon The Protein Kinase C Pathway Acts through Multiple Transcription Factors to Repress Gonadotropin-Releasing Hormone Gene Expression in Hypothalamic GT1-7 Neuronal Cells Mol. Endocrinol., November 1, 2005; 19(11): 2769 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rave-Harel, N. L. G. Miller, M. L. Givens, and P. L. Mellon The Groucho-related Gene Family Regulates the Gonadotropin-releasing Hormone Gene through Interaction with the Homeodomain Proteins MSX1 and OCT1 J. Biol. Chem., September 2, 2005; 280(35): 30975 - 30983. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Givens, R. Kurotani, N. Rave-Harel, N. L. G. Miller, and P. L. Mellon Phylogenetic Footprinting Reveals Evolutionarily Conserved Regions of the Gonadotropin-Releasing Hormone Gene that Enhance Cell-Specific Expression Mol. Endocrinol., December 1, 2004; 18(12): 2950 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nedelec, I. Foucher, I. Brunet, C. Bouillot, A. Prochiantz, and A. Trembleau Emx2 homeodomain transcription factor interacts with eukaryotic translation initiation factor 4E (eIF4E) in the axons of olfactory sensory neurons PNAS, July 20, 2004; 101(29): 10815 - 10820. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rave-Harel, M. L. Givens, S. B. Nelson, H. A. Duong, D. Coss, M. E. Clark, S. B. Hall, M. P. Kamps, and P. L. Mellon TALE Homeodomain Proteins Regulate Gonadotropin-releasing Hormone Gene Expression Independently and via Interactions with Oct-1 J. Biol. Chem., July 16, 2004; 279(29): 30287 - 30297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Martinez-Morales, V. Dolez, I. Rodrigo, R. Zaccarini, L. Leconte, P. Bovolenta, and S. Saule OTX2 Activates the Molecular Network Underlying Retina Pigment Epithelium Differentiation J. Biol. Chem., June 6, 2003; 278(24): 21721 - 21731. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Viczian, R. Vignali, M. E. Zuber, G. Barsacchi, and W. A. Harris XOtx5b and XOtx2 regulate photoreceptor and bipolar fates in the Xenopus retina Development, April 1, 2003; 130(7): 1281 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Kelley, M. L. Givens, N. Rave-Harel, S. B. Nelson, S. Anderson, and P. L. Mellon Neuron-Restricted Expression of the Rat Gonadotropin-Releasing Hormone Gene Is Conferred by a Cell-Specific Protein Complex that Binds Repeated CAATT Elements Mol. Endocrinol., November 1, 2002; 16(11): 2413 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Rosenberg and P. L. Mellon An Otx-Related Homeodomain Protein Binds an LH{beta} Promoter Element Important for Activation During Gonadotrope Maturation Mol. Endocrinol., June 1, 2002; 16(6): 1280 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lawson, L. A. Macconell, J. Kim, B. T. Powl, S. B. Nelson, and P. L. Mellon Neuron-Specific Expression in Vivo by Defined Transcription Regulatory Elements of the GnRH Gene Endocrinology, April 1, 2002; 143(4): 1404 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Kim, A. Wolfe, G. R. Smith, S. A. Tobet, and S. Radovick Promoter Sequences Targeting Tissue-specific Gene Expression of Hypothalamic and Ovarian Gonadotropin-releasing Hormone in Vivo J. Biol. Chem., February 8, 2002; 277(7): 5194 - 5202. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roy, N. L. Angelini, H. Fujieda, G. M. Brown, and D. D. Belsham Cyclical Regulation of GnRH Gene Expression in GT1-7 GnRH-Secreting Neurons by Melatonin Endocrinology, November 1, 2001; 142(11): 4711 - 4720. [Abstract] [Full Text] [PDF] |
||||